WAUKESHA, WI (August 14th, 2007) – Prodesse, Inc. today announced that it has taken an exclusive license for a method of Anti-Primer based Quantitative Real-Time PCR developed by Dr. G. Mike Makrigiorgos of Dana Farber Cancer Institute, a Teaching Affiliate of Harvard Medical School. A patent has been applied for and the anti-primer technology has already been adopted at multiple institutions worldwide.
